プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Krupa N.に依頼

Italy

Medical Writer & Visual Communicator | Publication Support & Medical Education | Oncology & Immunotherapy | ENG-native

プロフィール概要

I am a medical writer and scientific visual communicator with a PhD in Molecular Biotechnology and 15 years of translational research experience. My work spans oncology, cancer immunotherapy, antibody-drug conjugates, and infectious disease, with 23 peer-reviewed publications and 2 patents. I provide medical writing and publication support across the full publication lifecycle: manuscript drafting and editing, peer review responses, graphical abstracts, and plain-language summaries. For pharma and biotech clients, I develop medical education content for HCP audiences, including therapeutic area overviews, mechanism of action explainers, visual evidence summaries, and competitive landscape materials. My dual capability in scientific writing and visual communication means I can take a project from written brief to finished visual deliverable without handoffs between a writer and a separate designer. I work in English (native) and am an EMWA member. Current therapeutic area focus: immuno-oncology, ADCs, bispecific antibodies, antibody engineering and antimicrobial resistance.

専門分野

• ★ Immunotherapy
• ★ Medical Writing
• ★ Continuing Medical Education (CME) Materials
• ☆ Virology
• ☆ Coronaviruses
• ☆ Zika Virus
• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Omics
• ☆ Transcriptomics
• ☆ PCR
• ☆ Molecular Cloning
• ☆ Gene Expression Analysis
• ☆ Mutagenesis
• ☆ Recombinant DNA
• ☆ Plasmid DNA
• ☆ DNA Damage & Repair
• ☆ Monoclonal Antibody Production
• ☆ Cell Biology
• ☆ Biotechnology & Bioengineering
• ☆ Recombinant Protein Expression
• ☆ Biomedical Engineering
• ☆ Microscopy
• ☆ Fluorescence Microscopy
• ☆ Data Analysis
• ☆ Data Visualization
• ☆ Cell Culture
• ☆ Biomolecular Engineering
• ☆ Genetic Engineering
• ☆ Antibody Engineering
• ☆ Gene Delivery
• ☆ Visual Communication
• ☆ Drug Discovery
• ☆ High Throughput Screening (HTS)
• ☆ Drug Target Identification
• ☆ Hit-to-Lead & Lead Optimization
• ☆ Phenotypic Assays
• ☆ High Content Screening/Imaging
• ☆ Drug Development
• ☆ Preclinical Research
• ☆ In vitro Preclinical Toxciology
• ☆ Antibiotic Development
• ☆ Pharmaceutical Manufacturing
• ☆ Biologic & Biosimilar Manufacturing
• ☆ Clinical Trials
• ☆ Clinical Trials Data Analysis
• ☆ Dermatology
• ☆ Skin Cancer
• ☆ Precision Medicine
• ☆ Hematology
• ☆ Hematology-Oncology
• ☆ Leukemia & Lymphoma
• ☆ Infectious Disease
• ☆ Viral Diseases
• ☆ COVID-19
• ☆ Antibiotic Resistance Research
• ☆ Tropical Medicine
• ☆ Malaria
• ☆ Continuing Medical Education (CME)
• ☆ Public Health
• ☆ Global Health
• ☆ Disease Control And Prevention
• ☆ Gene Therapy
• ☆ Cancer Biology
• ☆ Peer Review
• ☆ Fact Checking
• ☆ Literature Search
• ☆ Presentation Design
• ☆ Graphic Design
• ☆ Process Design
• ☆ Medical Content Writing
• ☆ Healthcare Communications
• ☆ Patient Education Materials
• ☆ Research Summaries & Abstracts
• ☆ Medical Copywriting
• ☆ Technical & Scientific Writing
• ☆ Journal Selection
• ☆ Manuscript & Journal Article Writing
• ☆ Instructional Materials
• ☆ Experimental Protocols
• ☆ SOP & Protocol Writing
• ☆ White Papers
• ☆ Textbook Content Writing
• ☆ Science Communication
• ☆ Literature Review
• ☆ Traditional/Narrative Literature Review
• ☆ Systematic Literature Review
• ☆ Copywriting
• ☆ Blog Posts
• ☆ Scientific Proofreading & Editing
• ☆ Proofreading & Editing
• ☆ Creative Writing
• ☆ News Writing
• ☆ Grant Writing

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Medical Writing, Technical Writing, Copywriting, General Proofreading & Editing

Research Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Consulting Healthcare Consulting, Scientific and Technical Consulting

Data & AI Statistical Analysis, Data Visualization

職務経験

Freelance Scientific Communicator

The Erudite

1月 2025 - 現在

Medical/ Science writer

Medical Biotechnology & Immunotherapy Research Unit, UCT

1月 2020 - 現在

Senior Postdoctoral Fellow

University of Cape Town, South Africa

1月 2016 - 12月 2019

Postdoctoral Researcher

Department of Pathology, University of Cape Town

1月 2015 - 12月 2015

Research Internship

AstraZeneca India

8月 2013 - 10月 2013

学歴

Doctor of Philosophy (Ph.D) in Medical Microbiology & Bacteriology

University of Cape Town

1月 2011 - 12月 2014

Master of Science (MSc), Microbiology & Biotechnology

University of the Witwatersrand, South Africa

1月 2008 - 12月 2010

Bachelor of Science (Hons)

University of the Witwatersrand, South Africa

1月 2007 - 12月 2007

Bachelor of Science

University of the Witwatersrand, South Africa

1月 2004 - 12月 2006

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Krupa Naran, Dennis Makafui Dogbey, Stefan Barth (2025). Serpin B9‐Insensitive Granzyme B Mutant Delivered by Engineered Capsid AAV Vectors Demonstrates Selective Killing of EGFR‐Positive Cancer Cells . Advances in Cell and Gene Therapy.

Krupa Naran, Dennis Makafui Dogbey, Ursula-Claire Andong-Koung-Edzidzi, Gomolemo Atlegang Molope, Jesmika Singh, Tatenda Lovemore Bvudzijena, Stefan Barth (2024). EpCAM-targeting cancer immunotherapies: Evidence from clinical studies and the way forward . Tumor Discovery.

Krupa Naran, Gael Tchokomeni Siwe, Emmanuel Adebowale Fajemisin, Masala Mugeri, Stefan Barth (2024). Revisiting immunotherapeutic strategies for the management of atopic dermatitis . Exploration of Asthma & Allergy.

Krupa Naran, Gael Tchokomeni Siwe, Emmanuel Adebowale Fajemisin, Masala Mugeri, Stefan Barth (2024). Revisiting immunotherapeutic strategies for the management of atopic dermatitis . Exploration of Asthma & Allergy.

Krupa Naran, Neelakshi Mungra, Fleury A. Nsole Biteghe, Allan M. Huysamen, Natasha S. Hardcastle, Rubina Bunjun, Dirk Lang, Wolfgang Richter, Roger Hunter, Stefan Barth (2024). An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates . Molecular Pharmaceutics.

Krupa Naran, Musalula Sinkala, Dharanidharan Ramamurthy, Neelakshi Mungra, Kevin Dzobo, Darren Martin, Stefan Barth (2024). Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects . PLOS ONE.

Krupa Naran, Neelakshi Mungra, Fleury A. N. Biteghe, Zaria Malindi, Allan M. Huysamen, Maryam Karaan, Natasha S. Hardcastle, Rubina Bunjun, Shivan Chetty, Dirk Lang, et al. (2023). CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate . Journal of Cancer Research and Clinical Oncology.

Krupa Naran, Allan M. Huysamen, Olaolu E. Fadeyi, Grace Mayuni, Dennis M. Dogbey, Neelakshi Mungra, Fleury A. N. Biteghe, Natasha Hardcastle, Dharanidharan Ramamurthy, Olusiji A. Akinrinmade, et al. (2023). Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells . ACS Omega.

A K Daramola, O A Akinrinmade, E A Fajemisin, K Naran, N Mthembu, S Hadebe, F Brombacher, A M Huysamen, O E Fadeyi, R Hunter, et al. (2023). A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate . Immunotherapy Advances.

Krupa Naran, Stefan Barth (2022). TIM-3: a tumor-associated antigen beyond checkpoint inhibition? . Immunotherapy Advances.

Krupa Naran, Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, Neelakshi Mungra, Maryam Karaan, Stefan Barth (2021). Recent advances in immunotherapies against infectious diseases . Immunotherapy Advances.

(2020). Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies . Oncotarget.

(2020). Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma . Biomedicines.

Madheswaran S, Mungra N, Biteghe FAN, De la Croix Ndong J, Arowolo AT, Adeola HA, Ramamurthy D, Naran K, Khumalo NP, Barth S(2020). Antibody Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers . Anti-cancer agents in medicinal chemistry.

(2019). Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells . Oncotarget.

(2018). Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases . Frontiers in Microbiology.

(2018). Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells . Biomedicines.

(2016). Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery . Antimicrobial Agents and Chemotherapy.

(2016). Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis . ACS Infectious Diseases.

(2015). Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization . Bioorganic & Medicinal Chemistry.

(2014). Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c . Bioorganic & Medicinal Chemistry Letters.

Mjambili F, Njoroge M, Naran K, De Kock C, Smith PJ, Mizrahi V, Warner D, Chibale K(2013). Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents . Bioorganic & Medicinal Chemistry Letters.

(2013). Synthesis, Characterization, and Pharmacological Evaluation of Silicon-Containing Aminoquinoline Organometallic Complexes As Antiplasmodial, Antitumor, and Antimycobacterial Agents . Organometallics.

(2013). Synthesis and Antiplasmodial and Antimycobacterial Evaluation of New Nitroimidazole and Nitroimidazooxazine Derivatives . ACS Medicinal Chemistry Letters.